D-0482-2025 Class II Ongoing

Recalled by Thrive Health And Wellness, LLC, Dba Thrive Health Solutions (Colorado) — Englewood, CO

FDA drug recall D-0482-2025 was initiated by Thrive Health And Wellness, LLC, Dba Thrive Health Solutions (Colorado) on May 21, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is ongoing. Affected quantity: 24 syringes.

Recall details

Product Type
Drugs
Report Date
Jul 2, 2025
Initiation Date
May 21, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
24 syringes

Product description

Tirzepatide Injections, 10mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

USA Nationwide

Code information

Lot, expiry: H272962, exp 12/5/2025; S5045185, exp 5/20/2025; H272962, exp 12/5/2025; H270625, exp 9/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0482-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0482-2025. Report a data issue: hello@regdatalab.com.